Literature DB >> 10535445

Hypothalamic orexin expression: modulation by blood glucose and feeding.

X J Cai1, P S Widdowson, J Harrold, S Wilson, R E Buckingham, J R Arch, M Tadayyon, J C Clapham, J Wilding, G Williams.   

Abstract

Orexins (hypocretins), novel peptides expressed in specific neurons of the lateral hypothalamic area (LHA), stimulate feeding when injected intracerebroventricularly. We investigated their role in feeding in the rat by measuring hypothalamic prepro-orexin mRNA levels under contrasting conditions of increased hunger. Prepro-orexin mRNA levels increased significantly after 48 h of fasting (by 90-170%; P < 0.05) and after acute (6 h) hypoglycemia when food was withheld (by 90%; P < 0.02). By contrast, levels were unchanged during chronic food restriction, streptozotocin-induced diabetes, hypoglycemia when food was available, voluntary overconsumption of palatable food, or glucoprivation induced by systemic 2-deoxy-D-glucose. Orexin expression was not obviously related to changes in body weight, insulin, or leptin, but was stimulated under conditions of low plasma glucose in the absence of food. Orexins may participate in the short-term regulation of energy homeostasis by initiating feeding in response to falls in glucose and terminating it after food ingestion. The LHA is known to contain neurons that are stimulated by falls in circulating glucose but inhibited by feeding-related signals from the viscera; orexin neurons may correspond to this neuronal population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535445     DOI: 10.2337/diabetes.48.11.2132

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  61 in total

Review 1.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

2.  Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal.

Authors:  Dan Georgescu; Venetia Zachariou; Michel Barrot; Michihiro Mieda; Jon T Willie; Amelia J Eisch; Masashi Yanagisawa; Eric J Nestler; Ralph J DiLeone
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 3.  Neuroendocrine regulation of eating behavior.

Authors:  R Vettor; R Fabris; C Pagano; G Federspil
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

4.  Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels.

Authors:  Anne Venner; Mahesh M Karnani; J Antonio Gonzalez; Lise T Jensen; Lars Fugger; Denis Burdakov
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

5.  Afferents to the orexin neurons of the rat brain.

Authors:  Kyoko Yoshida; Sarah McCormack; Rodrigo A España; Amanda Crocker; Thomas E Scammell
Journal:  J Comp Neurol       Date:  2006-02-10       Impact factor: 3.215

Review 6.  Homeostasis Meets Motivation in the Battle to Control Food Intake.

Authors:  Carrie R Ferrario; Gwenaël Labouèbe; Shuai Liu; Edward H Nieh; Vanessa H Routh; Shengjin Xu; Eoin C O'Connor
Journal:  J Neurosci       Date:  2016-11-09       Impact factor: 6.167

7.  Hindbrain Catecholamine Neurons Activate Orexin Neurons During Systemic Glucoprivation in Male Rats.

Authors:  Ai-Jun Li; Qing Wang; Megan M Elsarelli; R Lane Brown; Sue Ritter
Journal:  Endocrinology       Date:  2015-05-15       Impact factor: 4.736

Review 8.  Multiple roles for orexin/hypocretin in addiction.

Authors:  Stephen V Mahler; Rachel J Smith; David E Moorman; Gregory C Sartor; Gary Aston-Jones
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

9.  Hedonic Eating: Sex Differences and Characterization of Orexin Activation and Signaling.

Authors:  Laura Buczek; Jennifer Migliaccio; Gorica D Petrovich
Journal:  Neuroscience       Date:  2020-04-10       Impact factor: 3.590

10.  Centrally administered orexin A increases motivation for sweet pellets in rats.

Authors:  A J Thorpe; J P Cleary; A S Levine; C M Kotz
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.